Key Takeaways
- • Eum Private Equity, a South Korean buyout firm, is set to acquire D&T Inc., a medical display maker, for approximately 500 billion won ($372.6 million).
- • The seller is Seoul-based Highland Equity Partners, which according to the report will roughly triple its invested capital in just over two years.
- • The deal was reported by investment banking industry sources on Thursday, November 5, 2026, and has not been confirmed in the source material as finalized.
Summary
Eum Private Equity, a South Korean buyout firm, is set to acquire D&T Inc., a medical display maker, for approximately 500 billion won, or $372.6 million, from Seoul-based Highland Equity Partners, according to investment banking industry sources cited by KED Global.
The transaction would allow Highland Equity Partners, the seller, to roughly triple its invested capital in just over two years, a return profile that highlights the value creation achieved during its holding period. D&T operates in the medical display segment, producing displays used in healthcare settings.
The report is based on sourcing from investment banking industry participants rather than an official announcement by the parties, so terms and timing remain subject to confirmation. The deal would mark a sizable buyout for Eum, adding a healthcare-technology hardware asset to its portfolio in South Korea.
The transaction would allow Highland Equity Partners, the seller, to roughly triple its invested capital in just over two years, a return profile that highlights the value creation achieved during its holding period. D&T operates in the medical display segment, producing displays used in healthcare settings.
The report is based on sourcing from investment banking industry participants rather than an official announcement by the parties, so terms and timing remain subject to confirmation. The deal would mark a sizable buyout for Eum, adding a healthcare-technology hardware asset to its portfolio in South Korea.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.